Testing effectiveness (Phase 2)WithdrawnNCT05147415What this trial is testingStudy of Tesomet With Open-label Extension in Subjects With Hypothalamic Obesity (HO)Who this might be right forHypothalamic Obesity Saniona
Large-scale testing (Phase 3)Study completedNCT00355615What this trial is testingPLUTO: Pediatric Lipid-redUction Trial of rOsuvastatinWho this might be right forFamilial Hypercholesterolemia AstraZeneca 173
Not applicableStudy completedNCT03850990What this trial is testingEffect of Gut-Cued Eating on BMI and Efficacy of Open-Label Placebo to Augment Weight LossWho this might be right forEating BehaviorObesityBody Weight+1 more University of Alabama at Birmingham 31
Large-scale testing (Phase 3)Ended earlyNCT04271475What this trial is testingEvaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary HypertensionWho this might be right forChronic Thromboembolic Pulmonary Hypertension Actelion 127
Early research (Phase 1)Study completedNCT02313064What this trial is testingOral CXA-10 Study in Healthy VolunteersWho this might be right forChronic Kidney Injury Complexa, Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT07641634What this trial is testingPRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.Who this might be right forHealthy VolunteersSystemic Sclerosis (SSc)Scleroderma, Systemic+1 more Prolium Bioscience, Inc 44
Not applicableStudy completedNCT02318719What this trial is testingDS-5565 Phase III Study for Post-herpetic NeuralgiaWho this might be right forPost-Herpetic Neuralgia Daiichi Sankyo Co., Ltd. 765
Testing effectiveness (Phase 2)Study completedNCT05445557What this trial is testingEvaluation of Safety and Efficacy of RZL-012 in Subjects Seeking Fat Reduction in the FlanksWho this might be right forFlank Mass Raziel Therapeutics Ltd. 12
Large-scale testing (Phase 3)Ended earlyNCT00532311What this trial is testingEfficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With HypercholesterolemiaWho this might be right forHypercholesterolemia Takeda 411
Early research (Phase 1)Study completedNCT01325415What this trial is testingA Placebo-controlled Four Way Crossover Study to Asses the Effect of a Single Oral Dose of NKTR-118 on QTc Interval in Healthy Male SubjectsWho this might be right forAmount of NKTR-118 in BloodVariation in the Heart's Electrical Cycle AstraZeneca 45
Testing effectiveness (Phase 2)Study completedNCT05616013What this trial is testingSafety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or ObeseWho this might be right forObesityObeseOverweight or Obesity Eli Lilly and Company 507
Early research (Phase 1)Study completedNCT01031589What this trial is testingTMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278Who this might be right forHIV Infections Tibotec Pharmaceuticals, Ireland 19
Testing effectiveness (Phase 2)Study completedNCT01426789What this trial is testingA Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) PatientsWho this might be right forRheumatoid Arthritis Novartis Pharmaceuticals 100
Large-scale testing (Phase 3)Study completedNCT00744731What this trial is testingAn Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset SeizuresWho this might be right forEpilepsy, Partial, MotorEpilepsy, Complex PartialEpilepsy, Simple Partial+1 more SK Life Science, Inc. 403
Large-scale testing (Phase 3)Study completedNCT00035802What this trial is testingEvaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I DisorderWho this might be right forBipolar DisorderAffective Disorders, PsychoticMood Disorders+1 more Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 13
Large-scale testing (Phase 3)Ended earlyNCT04825860What this trial is testingA Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension PhaseWho this might be right forSchizophrenia Sumitomo Pharma Co., Ltd. 83
Large-scale testing (Phase 3)Study completedNCT00929110What this trial is testing1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)Who this might be right forChronic Obstructive Pulmonary Disease Novartis 1,066
Large-scale testing (Phase 3)Study completedNCT02450526What this trial is testingDysport in the Treatment of Glabellar Lines in Chinese SubjectsWho this might be right forGlabellar Lines Ipsen 520
Testing effectiveness (Phase 2)Study completedNCT02214121What this trial is testingA Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor in Paediatric Patients With Sickle Cell DiseaseWho this might be right forInvestigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease AstraZeneca 46
Testing effectiveness (Phase 2)Study completedNCT01818921What this trial is testingAn Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi SyndromeWho this might be right forObesityOver-weightPrader-Willi Syndrome Zafgen, Inc. 17